UK: ECJ to be Asked for Guidance on Cobranding, De-branding and Notice in Relation to Parallel Imports

Last Updated: 21 April 2004
Article by Sumati Parikh

Boehringer Ingelheim KG & Anr -v- Swingward Lt; Boehringer Ingelheim KG & Ors -v- Dowelhurst Ltd; Glaxo Group Ltd v Swingward Ltd; Glaxo Group Ltd v Dowelhurst Ltd; Smithkline Beecham plc & Ors v Dowelhurst Ltd; and Eli Lilly v Dowelhurst Limited

Court of Appeal [2004] EWCA (Civ) 129 05/03/04

This parallel imports re-packaging case came before the UK Court of Appeal early this year having been through UK first instance decisions and the European Court of Justice ("ECJ"). Unfortunately, the matter is yet to be resolved as a further reference to the ECJ is being made for guidance on co-branding, de-branding and notice to a trade mark proprietor in relation to parallel imports.


The Claimants in the various actions (Boehringer Ingelheim, Glaxo, SmithKline Beecham and Eli Lilly) are well known pharmaceutical manufacturers. The Defendants (Swingward Limited and Dowelhurst Limited) are parallel importers of trade marked pharmaceuticals and dealers in generic pharmaceuticals. The actions were principally for infringement of registered trade marks although Boehringer Ingelheim also claimed passing off.

The goods in question were genuine pharmaceutical products – either pills packed in blister packs or labelled inhalers. These goods were purchased in a European Economic Area ("EEA") Member State outside the UK and then either re-boxed in English language boxes with information leaflets in English or over-labelled with English language labels before being sold in the UK. In some instances the importer had used only the generic name of the drug on the box and not its trade mark ("de-branding"). In some other instances the importers’ new boxes carried the trade mark of the drug and a "get up" which was distinctive of the importer ("co-branding").

Irrespective of whether there was re-boxing or stickering, the importer indicated clearly on the new box or the sticker that the goods had been procured in the EU and had been re-packaged by the importer.


The Court of Appeal had to decide on the following:

  • can importers re-box at all, and if so, whether the way they had done it was lawful;
  • can the importers co-brand or de-brand; and
  • what is the notice period required to be given by the importer to the trade mark proprietor.

According to Article 7 of the Trade Marks Directive once goods have been put on the market in the EEA under a trade mark by the proprietor or with his consent, the proprietor cannot restrict the use of the trade mark in relation to those goods unless there exist legitimate reasons for a proprietor to oppose further commercialisation of the goods (such as where the condition of the goods is changed or impaired).

The trade mark proprietors argued that they had legitimate reasons to oppose further commercialisation of the pharmaceutical products. On the other hand, the parallel importers said that enforcement of the trade mark rights in this case would constitute "disguised restriction on trade between Member States" and thus contravene Article 30 of the EC treaty. They also denied the existence of any legitimate reasons under Article 7.


Repackaging- The Court of Appeal judgment was given by Jacob LJ. He said that when an importer repackages and reapplies the mark, he infringes the mark unless he satisfies all five conditions laid down in the case of Bristol-Myers Squibb v Paranova by the ECJ ("the BMS conditions"). These conditions are that:

  1. it was necessary for the importer to repackage the product in order to market the product in the Member State of importation;
  2. there is no effect on the original condition of the product inside the packaging and the product carries proper instructions with it;
  3. the new packaging clearly states who repackaged the product and the name of the manufacturer in print;
  4. the presentation of the repackaged product is not such as to be liable to damage the reputation of the trade mark and of its owner; and
  5. the importer has given notice to the trade mark proprietor before the repackaged product is put on sale and, on demand, supplied him with a specimen of the repackaged product.

Jacob LJ’s view was that parallel importers are entitled to replace the packaging if that is what is necessary to overcome a strong resistance from a significant proportion of consumers in the market to relabelled boxes. On reviewing the evidence before him, Jacob LJ concluded that if parallel importers cannot re-box they face a substantial hindrance to sale.

Passing off- Jacob LJ rejected Boehringer’s argument that the use of only the generic name of the drug on the box made a false representation that the drug inside was sourced from a generic manufacturer chosen by Dowelhurst, and that this led to damage and passing off. Jacob LJ said that the generic name on the box was true – for instance the box saying "Meloxican tablets 15mg," contained just that. There was no evidence that any pharmacist or patient had ever been deceived notwithstanding significant sales of the products.

Co-branding and de-branding- Jacob LJ criticised the judgment given at first instance by Laddie J on these two issues. He said that Laddie J was wrong in his view that the ECJ had created an "irrebuttable presumption that re-packaging is prejudicial to the specific subject matter of a trade mark".

Jacob LJ’s view was that, so far as co-branding is concerned, in some circumstances it may cause damage to the reputation of the mark, for instance, if the co-brand created a deception that it was a brand of the actual manufacturer, or that the importer and the manufacturer were in some sort of joint venture. However, this was not so on the facts of this case. Moreover notices were present on the product in accordance with BMS condition 3. Therefore damage to reputation was not self-evident.

On de-branding, again Jacob LJ saw no damage to the reputation of the Claimants or their trade marks. The Claimants had submitted that the ever decreasing exposure of the trade marks will cause damage. Jacob LJ rejected this stating that the trade mark owner does not have any right that requires subsequent dealers in his product to keep his trade mark on the product.

Looking at it another way, he said that the only act which would be an infringement is the act of affixing the trade mark. The only such acts in the case of a de-branding exercise are the affixing of the trade mark on the patient information leaflets as to which no objection can be taken and the use of the manufacturer’s name in the BMS condition 3 notice, which again is unarguably legitimate.

Jacob LJ concluded that Laddie J had got it wrong and that if it was left to him he would allow the appeals. However, due to the substantial disparity of views across the EU he said that a reference to the ECJ was necessary.

He mentioned four EU cases concerning co-branding and use of a distinctive mark of the parallel importer. All such packaging had been held by the respective EU national courts to be infringing.

On the other hand, the EFTA Court of Appeal concerned with exactly the same problem had come to an opposite conclusion in a judgment of 8 July 2003 in Paranova v Merck. The EFTA Court was of the view that use of coloured stripes on packaging in accordance with the importer’s housestyle could not by itself constitute a legitimate reason within the meaning of Article 7 as long as the names of the manufacturer and the parallel importer are adequately stated on the packaging.

Period of notice- Jacob LJ said there should be no difference in the period of notice needed by a trade mark proprietor to consider a stickered product and that needed to consider a re-boxed product. In relation to both, there is not just a question of appearance involved but also, at least a preliminary factual assessment of whether a damage to reputation is likely. He held that an appropriate notice period in relation to all the re-boxing and stickering or over-labelling in dispute in this case was 15 working days.

Suggestions for reference- Jacob LJ suggested that there should be a question about what "necessary" means (in BMS condition 1). Guidance is required on the rules for stickering and re-boxing and on whether parallel imports made without giving notice to the proprietor must be regarded as infringement with the particular consequence that an importer must pay damages or render an account of the profits he has made.


It is unlikely that any guidance from the ECJ will fully resolve the problems being faced by various EU national courts. It is also unlikely to bring about a uniformity in approach to the interpretation of the rules for packaging set out in various ECJ judgements so far. At the end of the day, it will be left to the national courts to decide issues of infringement on the facts of a particular case, the type of get-up and the use of the mark(s) on the packaging. In fact, although Jacob LJ was able to decide on all issues in this case based on the facts before him, he decided not to give judgment and instead make a reference to the ECJ as he felt it necessary that the disparity between EU national courts and the EFTA Court of Appeal be resolved. We wait and see.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.